427886-22-4

Basic information

• Product Name: 4-Pyridinecarboxylic acid, 2-(4-chloro-3,5-dimethoxyphenyl)-, ethyl ester
• CAS NO: 427886-22-4
• Molecular Formula: C16H16ClNO4
• Molecular Weight: 321.76
• Mol File: 427886-22-4.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 4-Pyridinecarboxylic acid, 2-(4-chloro-3,5-dimethoxyphenyl)-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Pyridinecarboxylic acid, 2-(4-chloro-3,5-dimethoxyphenyl)-, ethyl ester(427886-22-4)
• EPA Substance Registry System: 4-Pyridinecarboxylic acid, 2-(4-chloro-3,5-dimethoxyphenyl)-, ethyl ester(427886-22-4)

Safety Data

• Hazardous Substances Data: 427886-22-4(Hazardous Substances Data)

Upstream product

• 427886-21-3 4-Chloro-3,5-dimethoxyphenylboronic acid 
• 54453-93-9 ethyl 2-chloroisonicotinate 

Downstream Products

• 427886-23-5 2-(4-chloro-3,5-dimethoxyphenyl)isonicotinic acid 

Relevant articles and documents

Cyclic amine compounds and pharmaceutical composition containing the same

A cyclic amine compound represented by the following general formula (1): wherein, R1, R2 and R3 each independently represent a hydrogen atom or an alkoxy group;W1 and W2 each independently represent N or CH;X represents O, NR4, CONR4 or NR4CO;R4 represents a hydrogen atom, or an alkyl, aryl, heteroaryl, aralkyl, or heteroaralkyl group; andl, m and n each represents a number of 0 or 1, a salt thereof and a hydrate thereof are provided. These compounds have inhibitory effects on both cell adhesion and cell infiltration and are useful as anti-asthmatic agents, anti-allergic agents, anti-rheumatic agents, anti-arteriosclerotic agents, anti-inflammatory agents, anti-Sjogren's syndrome agents or the like.

Cyclic amine compounds and pharmaceutical composition containing the same

A cyclic amine compound represented by the following general formula (1): wherein, R1, R2 and R3 each independently represent a hydrogen atom or an alkoxy group; W1 and W2 each independently represent N or CH; X represents O, NR4, CONR4 or NR4CO; R4 represents a hydrogen atom, or an alkyl, aryl, heteroaryl, aralkyl, or heteroaralkyl group; and l, m and n each represents a number of 0 or 1, a salt thereof and a hydrate thereof are provided. These compounds have inhibitory effects on both cell adhesion and cell infiltration and are useful as anti-asthmatic agents, anti-allergic agents, anti-rheumatic agents, anti-arteriosclerotic agents, anti-inflammatory agents, anti-Sjogren's syndrome agents or the like.

Cyclic amine compounds and pharmaceutical composition containing the same

A cyclic amine compound represented by the following general formula (1): wherein, R1, R2and R3each independently represent a hydrogen atom or an alkoxy group; W1and W2each independently represent N or CH; X represents O, NR4, CONR4or NR4CO; R4each independently represents a hydrogen atom, or an alkyl, aryl, heteroaryl, aralkyl, or heteroaralkyl group; and l, m and n each represents a number of 0 or 1, a salt thereof and a hydrate thereof are provided. These compounds have inhibitory effects on both cell adhesion and cell infiltration and are useful as anti-asthmatic agents, anti-allergic agents, anti-rheumatic agents, anti-arteriosclerotic agents, anti-inflammatory agents, anti-Sjogren's syndrome agents or the like.